Citi Starts Integer Holding (ITGR) at Neutral, 'Industry Leader Easing Manufacturing'

Citi analyst Joanne Wuensch initiates coverage on Integer Holding (NYSE: ITGR) with a Neutral rating and a price target of $88.00.

The analyst comments "We are initiating coverage of Integer Holdings (ITGR), a global healthcare leader in the medical device outsource (MDO) manufacturing arena, servicing medical device companies (including many household names) as well as non-medical companies (e.g., in the military, energy, and environmental sectors). The company has evolved, grown, and faced obstacles (including the global pandemic) building on a turnaround that began with Joseph Dziedzic taking the helm as CEO in 2017. It has also made acquisitions and divestitures as it has formulated the portfolio to address the R&D and manufacturing needs of companies, providing the needed expertise across the cardiac rhythm management, neuromodulation, orthopedics, vascular, and the advanced surgical and portable medical space. While we believe its leading market share should position it to capitalize on recovering procedure volumes and industry consolidation, at the current valuation we are stepping into coverage of ITGR with a Neutral rating and $88 target price."

For an analyst ratings summary and ratings history on Integer Holding click here. For more ratings news on Integer Holding click here.

Shares of Integer Holding closed at $79.48 yesterday.

You May Also Be Interested In

• Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
• UBS Double Upgrades China Resources Power Holdings (836:HK) (CRPJY) to Buy
• BorgWarner (BWA) PT Raised to $95 at Wolfe Research, 'Bullish Takeaways from CEO Meetings'